deferiprone has been researched along with Anemia, Iron-Deficiency in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Anemia, Iron-Deficiency: Anemia characterized by decreased or absent iron stores, low serum iron concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the iron binding capacity is increased.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sohn, YS | 1 |
| Mitterstiller, AM | 1 |
| Breuer, W | 1 |
| Weiss, G | 1 |
| Cabantchik, ZI | 1 |
1 other study available for deferiprone and Anemia, Iron-Deficiency
| Article | Year |
|---|---|
Rescuing iron-overloaded macrophages by conservative relocation of the accumulated metal.
Topics: Anemia, Iron-Deficiency; Animals; Antimicrobial Cationic Peptides; Biological Transport; Cation Tran | 2011 |